Science Explorer Interactive view Map
Hospital / health system · Bellinzona · ??

Istituto Oncologico della Svizzera Italiana

eoc.ch/ospedali-e-istituti/istituto-oncologico-della-svizzera-italiana.htmlROR OpenAlex
Research works
5
fractional, all time
Citations
16
3.4 per fractional work
Top-10% rate
24.4%
record average 16.5%
Open access
75%
world 28%

Not ranked overall: Istituto Oncologico della Svizzera Italiana is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.20× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.00× its world share, 0 worksImmunology and Micro…Chemistry: 1.22× its world share, 0 worksChemistryEngineering: 0.27× its world share, 0 worksEngineeringMaterials Science: 0.22× its world share, 0 worksMaterials ScienceMedicine: 3.81× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.

Which research topics does Istituto Oncologico della Svizzera Italiana publish most on?

By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors and Cancer Immunotherapy and Biomarkers.

Lymphoma Diagnosis and T…1Lymphoma Diagnosis and Treatment: 1 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksProtein Degradation and …0Protein Degradation and Inhibitors: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksCAR-T cell therapy research: 0 fractional worksCardiac tumors and thrombi0Cardiac tumors and thrombi: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksGalectins and Cancer Biology: 0 fractional worksCell death mechanisms and regulation: 0 fractional worksPulmonary Hypertension Research and Treatments: 0 fractional works
Pathology and Forensic MedicineGeneticsMolecular BiologyOncology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 0 works
  3. 3 Protein Degradation and Inhibitors Molecular Biology 0 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 CAR-T cell therapy research Oncology 0 works
  6. 6 Cardiac tumors and thrombi Cardiology and Cardiovascular Medicine 0 works
  7. 7 Cancer Genomics and Diagnostics Cancer Research 0 works
  8. 8 Galectins and Cancer Biology Immunology 0 works
  9. 9 Cell death mechanisms and regulation Molecular Biology 0 works
  10. 10 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available75.1%not open24.9%

World: 28% of research is openly available.

with international co-authors74.2%domestic only25.8%

World: 19% is written across borders.

How has Istituto Oncologico della Svizzera Italiana's research output changed?

2020

Other research institutions in Bellinzona

All research institutions in Bellinzona

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.